<DOC>
	<DOC>NCT01887275</DOC>
	<brief_summary>The purpose of this study is to investigate the efficacy and safety of medical ozone in treatment of chronic hepatitis B patients.</brief_summary>
	<brief_title>A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis B</brief_title>
	<detailed_description>Total of 439 patients with chronic hepatitis B were divided according to patients' intention into two arms. 173 patients in arm I were treated with medical ozone therapy with humares which was made in Germany for at least 12 weeks.266 patients in arm II were treated with conventional interferon-α for at least 24 weeks.Patients in both groups were followed-up for 24 weeks.Virology response, biochemistry response and hepatitis B viral serological response will be studied at 12 weeks after the treatment, at the end of treatment and after 24 weeks of follow-up.</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B, Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<criteria>Male or female； HBsAg positive for over 6 months； ALT over 2×ULN, TBIL less than 80 µmol/L. Patient has a history of hemorrhagic or hemolysis disease; Patient has any history of clinical signs/symptoms of hepatic decompensation or serious metabolic hepatic disease; Patient is coinfected with HIV or HCV; Patient is treated with antivirus drug like interferon or nucleoside analogue in recent 6 months; Patient is treated with immunosuppressive agent for long time, including patient has a history of organ transplantation; Pregnancy; Current alcohol or drug abuse; Difficulty to draw blood through veins; Patient has a history of carcinoma, or finding suggestive of possible hepatocellular carcinoma (HCC), or AFP over than 100ng/ml; Patient has a history of any severe physical disease such as cardiovascular, kidney events, hyperthyroidism or serious electrolyte disturbance; Patient is enrolled in any other clinical trials.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Chronic hepatitis B</keyword>
	<keyword>Medical Ozone</keyword>
	<keyword>Interferon-α</keyword>
	<keyword>Efficacy</keyword>
</DOC>